The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking

David E. Comings, Linda Ferry, Susan Bradshaw-Robinson, R. Burchette, C. Chiu, D. Muhleman

Research output: Contribution to journalArticlepeer-review

Abstract

Of a group of 312 non-Hispanic Caucasians who smoked at least one pack per day, had unsuccessfully attempted to stop smoking, and were free of alcohol or other drug dependence, 48.7% carried the A1 allele of the DRD2 gene. This was significantly greater than the 25.9% prevalence in the 714 known non-Hispanic Caucasian controls without alcohol or drug abuse, p<10-8, and significantly greater than in a smaller set of our study controls. There was a significant, inverse relationship between the prevalence of the D2A1 allele and the age of onset of smoking, p = 0.02, and the maximum duration of time the smokers had been able to quit smoking on their own, p = 0.02. These results suggest the DRD2 gene is one of a multifactorial set of risk factors associated with smoking.

Original languageEnglish
Pages (from-to)73-79
Number of pages7
JournalPharmacogenetics
Volume6
Issue number1
DOIs
StatePublished - 1996

ASJC Scopus Subject Areas

  • Genetics
  • General Pharmacology, Toxicology and Pharmaceutics

Keywords

  • DRD2
  • addiction
  • dopamine
  • nicotine
  • receptors
  • smoking
  • tobacco

Cite this